Coverage Information | Repatha® (evolocumab) - repathahcp.com

Contraindications: Repatha ® is contraindicated in patients with a history of a serious hypersensitivity reaction to evolocumab or any of the excipients in Repatha ®. Serious …

CouponFollow Extension

$561.49
OFF

Repatha® (evolocumab) Cost And Co-Pay Card Information

1 week from now

Jan 5, 2024 · The list price for Repatha ® is $561.49* † per month. Most patients do not pay the list price. Your actual cost will vary and will depend on your insurance coverage. Refer to the …

repatha.com

$561.49
OFF

Repatha® (evolocumab) Cost And Co-Pay Card Information

1 week from now

repatha.com

FAQs about Coverage Information | Repatha® (evolocumab) - repathahcp.com Coupon?

Is Repatha contraindicated in patients with evolocumab?

REPATHA is contraindicated in patients with a history of a serious hypersensitivity reaction to evolocumab or any of the excipients in REPATHA. Serious hypersensitivity reactions including ... 5.1 Hypersensitivity Reactions - Hypersensitivity reactions, including angioedema, have been reported in patients treated with REPATHA. ...

Can I take Repatha ® If I'm allergic to evolocumab?

Whether you’re considering Repatha ® or already have a prescription, helpful resources are available to support you on your path to lower LDL-C (“bad” cholesterol) and to reduce your risk of heart attack or stroke. Do not use Repatha® if you are allergic to evolocumab or to any of the ingredients in Repatha ®. ...

When will evolocumab (Repatha®) be updated?

Updates will be made when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. Evolocumab (REPATHA®) is a humanized monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9). ...

Is Repatha (evolocumab) safe?

The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Repatha (evolocumab) is used to treat high cholesterol and to reduce risks in people with heart disease. Learn about side effects, cost, and more. ...

What does evolocumab do in Repatha?

The active drug in Repatha, evolocumab, is a monoclonal IgG2 antibody. It targets proprotein convertase subtilisin kexin type 9 (PCSK9), a protein that mediates LDL receptor degradation. Inhibition of PCSK9 increases the number of low-density lipoprotein (LDL) receptors available to remove LDL from the blood. ...

Is Repatha ® a monoclonal antibody?

Immunogenicity: Repatha ® is a human monoclonal antibody. As with all therapeutic proteins, there is potential for immunogenicity with Repatha ®. In adults with established cardiovascular disease to reduce the risk of myocardial infarction, stroke, and coronary revascularization. Please see full Prescribing Information. ...